Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates

Nature Cell Biology

Volumn 11, Issue 2, 2009, Pages 219-225

  Ren, Pei Hsien ^a   Lauckner, Jane E ^a   Kachirskaia, Ioulia ^a   Heuser, John E ^c   Melki, Ronald ^b   Kopito, Ron R ^a  

^a STANFORD UNIVERSITY   (United States)

^b LABORATOIRE D ENZYMOLOGIE ET BIOCHIMIE STRUCTURALES   (France)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; CHAPERONE; POLYGLUTAMINE; UBIQUITIN;

ARTICLE; CELL AGGREGATION; CELL COMPARTMENTALIZATION; CELL CULTURE; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; DEGENERATIVE DISEASE; GENE SEQUENCE; HERITABILITY; HUMAN; HUMAN CELL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION;

AMYLOID; AMYLOIDOSIS; CELL COMMUNICATION; CELL LINE; CYTOPLASM; DISEASE TRANSMISSION, INFECTIOUS; ENDOCYTOSIS; HUMANS; HUNTINGTON DISEASE; INCLUSION BODIES; NEURODEGENERATIVE DISEASES; NEUROFIBRILS; PEPTIDES; PRION DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; TRINUCLEOTIDE REPEAT EXPANSION;

MAMMALIA;

EID: 59649095699     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1830     Document Type: Article

References (27)

1. Chiti, F. & Dobson, C. M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75, 333-366 (2006).
2. Taylor, J. P., Hardy, J. & Fischbeck, K. H. Toxic proteins in neurodegenerative disease. Science 296, 1991-1995 (2002).
3. Carrell, R. W. & Lomas, D. A. Conformational disease. Lancet 350, 134-138 (1997).
4. Pepys, M. B. Amyloidosis. Annu. Rev. Med. 57, 223-241 (2006).
5. Sousa, M. M., Cardoso, I., Fernandes, R., Guimaraes, A. & Saraiva, M. J. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: Evidence for toxicity of nonfibrillar aggregates. Am. J. Pathol. 159, 1993-2000 (2001).
6. Ross, C. A. & Poirier, M. A. Protein aggregation and neurodegenerative disease. Nature Med. 10, S10-17 (2004).
7. Bucciantini, M. et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416 507-511 (2002).
8. Yang, W., Dunlap, J. R., Andrews, R. B. & Wetzel, R. Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum. Mol. Genet. 11, 2905-2917 (2002).
9. Morten, I. J., Gosal, W. S., Radford, S. E. & Hewitt, E. W. Investigation into the role of macrophages in the formation and degradation of beta2-microglobulin amyloid fibrils. J. Biol. Chem. 282, 29691-29700 (2007).
10. Lee, H. J. et al. Assembly-dependent endocytosis and clearance of extracellular α-synuclein. Int. J. Biochem. Cell Biol. 40, 1835-1849 (2008).
11. Li, J. Y. et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nature Med. 14, 501-503 (2008).
12. Chen, S. & Wetzel, R. Solubilization and disaggregation of polyglutamine peptides. Protein Sci. 10, 887-891 (2001).
13. Chen, S., Berthelier, V., Hamilton, J. B., O'Nuallain, B. & Wetzel, R. Amyloid-like features of polyglutamine aggregates and their assembly kinetics. Biochemistry 41, 7391-7399 (2002).
14. Heuser, J. The production of 'cell cortices' for light and electron microscopy. Traffic 1, 545-552 (2000).
15. Jana, N. R., Tanaka, M., Wang, G. & Nukina, N. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: Their role in suppression of aggregation and cellular toxicity. Hum. Mol. Genet. 9, 2009-2018 (2000).
16. Cohen, F. E. Protein misfolding and prion diseases. J. Mol. Biol. 293, 313-320 (1999).
17. Santoso, A., Chien, P., Osherovich, L. Z. & Weissman, J. S. Molecular basis of a yeast prion species barrier. Cell 100, 277-288 (2000).
18. Rujano, M. A. et al. Polarised asymmetric inheritance of accumulated protein damage in higher eukaryotes. PLoS Biol. 4 e417 (2006).
19. Kayed, R. et al. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279, 46363-46366 (2004).
20. Porat, Y., Kolusheva, S., Jelinek, R. & Gazit, E. The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies. Biochemistry 42, 10971-10977 (2003).
21. Khémtemourian, L., Killian, J. A., Hoppener, J. W. & Engel, M. F. Recent insights in islet amyloid polypeptide-induced membrane disruption and its role in β-cell death in type 2 diabetes mellitus. Exp. Diabetes Res. 2008, 421287 (2008).
22. Chen, S., Berthelier, V., Yang, W. & Wetzel, R. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J. Mol. Biol. 311, 173-182 (2001).
23. DePace, A. H., Santoso, A., Hillner, P. & Weissman, J. S. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93, 1241-1252 (1998).
24. Scherzinger, E. et al. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington's disease pathology. Proc. Natl Acad. Sci. USA 96 4604-4609 (1999).
25. Heuser, J. Three-dimensional visualization of coated vesicle formation in fibroblasts. J. Cell Biol. 84, 560-583 (1980).
26. Wanker, E. E. et al. Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates. Methods Enzymol. 309, 375-386 (1999).
27. Scherzinger, E. et al. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549-558 (1997).